| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,953 |
13,915 |
$1.28M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,385 |
11,676 |
$807K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
611 |
583 |
$75K |
| 99205 |
Prolong outpt/office vis |
198 |
190 |
$32K |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
26 |
26 |
$31K |
| 81025 |
|
3,506 |
2,256 |
$27K |
| H0049 |
Alcohol and/or drug screening |
1,582 |
1,540 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
464 |
418 |
$15K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
168 |
157 |
$14K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,317 |
1,263 |
$14K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
424 |
411 |
$12K |
| 90832 |
Psychotherapy, 30 minutes with patient |
243 |
230 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
935 |
804 |
$12K |
| 99354 |
|
131 |
126 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
418 |
405 |
$8K |
| 99215 |
Prolong outpt/office vis |
68 |
67 |
$8K |
| 90686 |
|
215 |
209 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
22 |
21 |
$2K |
| 90674 |
|
85 |
85 |
$1K |
| 90756 |
|
77 |
77 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
16 |
16 |
$1K |
| 90658 |
|
79 |
77 |
$1K |
| 99406 |
|
111 |
101 |
$988.67 |
| 96127 |
|
81 |
77 |
$806.72 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
99 |
81 |
$796.09 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
14 |
$459.94 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
12 |
12 |
$458.52 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
430 |
380 |
$430.55 |
| 93000 |
|
31 |
26 |
$396.14 |
| 98926 |
|
19 |
12 |
$301.35 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13 |
12 |
$245.76 |
| 81002 |
|
82 |
70 |
$245.57 |
| 90656 |
|
12 |
12 |
$223.50 |
| 36415 |
Collection of venous blood by venipuncture |
60 |
56 |
$155.00 |
| 99415 |
Prolong outpt/office vis |
17 |
17 |
$113.76 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
13 |
12 |
$106.08 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
21 |
16 |
$75.79 |
| 3078F |
|
13 |
13 |
$0.00 |
| 3079F |
|
13 |
13 |
$0.00 |
| 3074F |
|
56 |
54 |
$0.00 |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
17 |
15 |
$0.00 |
| 3075F |
|
12 |
12 |
$0.00 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
14 |
13 |
$0.00 |